Evidence map›Paper›PMID 37333894›Full record

ArticlePhysics and imaging in radiation oncology2023

Deep-learning magnetic resonance imaging-based automatic segmentation for organs-at-risk in the brain: Accuracy and impact on dose distribution.

Andrada Turcas, Daniel Leucuta, Cristina Balan, Enrico Clementel, Cristina Gheara, Alex Kacso, Sarah M Kelly, Delia Tanasa, Dana Cernea, Patriciu Achimas-Cadariu

Open access · goldAbstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Multimodal PET-MR segmentation for glioblastoma: complementarity for treatment planning and recurrence definition.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Clinical evaluation of two glioblastoma delineation methods based on neural networks.Technical innovations & patient support in radiation oncology · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Andrada TurcasThe European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, RTQA, Brussels, Belgium.
Daniel LeucutaUniversity of Medicine and Pharmacy "Iuliu Hatieganu", Department of Medical Informatics and Biostatistics, Cluj-Napoca, Romania.
Cristina BalanOncology Institute "Prof. Dr. Ion Chiricuta", Radiotherapy Department, Cluj-Napoca, Romania.
Enrico ClementelThe European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, RTQA, Brussels, Belgium.
Cristina GhearaOncology Institute "Prof. Dr. Ion Chiricuta", Radiotherapy Department, Cluj-Napoca, Romania.
Alex KacsoUniversity of Medicine and Pharmacy and Medicine "Iuliu Hatieganu", Oncology Department, Cluj-Napoca, Romania.
Sarah M KellyThe European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, RTQA, Brussels, Belgium.
Delia TanasaOncology Institute "Prof. Dr. Ion Chiricuta", Radiotherapy Department, Cluj-Napoca, Romania.
Dana CerneaOncology Institute "Prof. Dr. Ion Chiricuta", Radiotherapy Department, Cluj-Napoca, Romania.
Patriciu Achimas-CadariuUniversity of Medicine and Pharmacy and Medicine "Iuliu Hatieganu", Oncology Department, Cluj-Napoca, Romania.
Institute of Oncology Prof. Dr. Ion Chiricuta · ROEuropean Organisation for Research and Treatment of Cancer · BEIuliu Hațieganu University of Medicine and Pharmacy · ROBabeș-Bolyai University · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Normal tissue sparing in radiotherapy relies on proper delineation. While manual contouring is time consuming and subject to inter-observer variability, auto-contouring could optimize workflows and harmonize practice. We assessed the accuracy of a commercial, deep-learning, MRI-based tool for brain organs-at-risk delineation. Materials and methods: Thirty adult brain tumor patients were retrospectively manually recontoured. Two additional structure sets were obtained: AI (artificial intelligence) and AIedit (manually corrected auto-contours). For 15 selected cases, identical plans were optimized for each structure set. We used Dice Similarity Coefficient (DSC) and mean surface-distance (MSD) for geometric comparison and gamma analysis and dose-volume-histogram comparison for dose metrics evaluation. Wilcoxon signed-ranks test was used for paired data, Spearman coefficient(ρ) for correlations and Bland-Altman plots to assess level of agreement. Results: Auto-contouring was significantly faster than manual (1.1/20 min, p < 0.01). Median DSC and MSD were 0.7/0.9 mm for AI and 0.8/0.5 mm for AIedit. DSC was significantly correlated with structure size (ρ = 0.76, p < 0.01), with higher DSC for large structures. Median gamma pass rate was 74% (71-81%) for Plan_AI and 82% (75-86%) for Plan_AIedit, with no correlation with DSC or MSD. Differences between Dmean_AI and Dmean_Ref were ≤ 0.2 Gy (p < 0.05). The dose difference was moderately correlated with DSC. Bland Altman plot showed minimal discrepancy (0.1/0) between AI and reference Dmean/Dmax. Conclusions: The AI-model showed good accuracy for large structures, but developments are required for smaller ones. Auto-segmentation was significantly faster, with minor differences in dose distribution caused by geometric variations.

Indexed as

Artificial IntelligenceBrain tumorsDelineation/contouringRadiation OncologyRadiotherapyTreatment planning

Identifiers

PMID37333894
PMCPMC10276287
OpenAlexW4379536064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.